Huaigeng Xu was born in China and grew up in Japan.
He obtained his MD and PhD in Japan and recently started working at UCSF from March 2020.
During his PhD, he generated low immunogenicity iPS cells by disrupting HLA genes via CRISPR-Cas9 based genome-editing (Xu et al, Cell Stem Cell, 2019).
During this work, he learned iPS cell culture and differentiation to blood cells, CRISPR-Cas9 genome editing, immunology (e.g. T cells, NK cells and immune rejection) and basic mouse experiments.
His personal interest is aging, and his ultimate goal in the future is to solve age-related health problems and manage his longevity.
He speaks both Japanese and Chinese, and he is willing to interact with a lot of people.